Dyax Corp.

(DYAX)

By |

Profile

Dyax Corp is a biopharmaceutical company focused on Hereditary Angioedema and Other Plasma-Kallikrein-Mediated (PKM)Disorders and Licensing and Funded Research Portfolio.

Issuer Information

NAICS: 541711
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi 38.56 52 Wk Low 14.06
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 147,184,538.00 EPS (TTM) -0.21 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 77
Number of Buys 0 69
Number of Sells 0 8
Net Activity 0 4773317
Last 10 Buys Shares
Marc Kozin 1,000
Marc Kozin 1,000
Marc Kozin 1,000
Marc Kozin 1,000
Marc Kozin 1,000
Marc Kozin 1,000
Gustav A. Christensen 1,000
Gustav A. Christensen 1,000
Gustav A. Christensen 1,000
Gustav A. Christensen 1,000
Last 10 Sell Shares
Thomas L. Kempner 1,000
Thomas L. Kempner 1,000
Thomas L. Kempner 1,000
Thomas L. Kempner 1,000
Thomas L. Kempner 1,000
Thomas L. Kempner 1,000
Thomas L. Kempner 1,000
Thomas L. Kempner 1,000
Thomas L. Kempner 1,000
George V. Migausky 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 37.3 37.3 37.3 37.3
Low Target Price Estimate 30 30 30 30
Mean Target Price Estimate 34.72 34.72 34.72 34.72
Standard Deviation 3.66 3.66 3.66 3.66
Date of Most Recent Estimate 12/02/15 12/02/15 12/02/15 12/02/15
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 5
Moderate Buy 1 1 1 2
Hold 4 4 4 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.29 2.29 2.29 1.5